This warning banner provides privacy and security notices consistent with applicable federal laws, directives, and other federal guidance for accessing this Government system, which includes (1) this computer network, (2) all computers connected to this network, and (3) all devices and storage media attached to this network or to a computer on this network.
This system is provided for Government-authorized use only.
Unauthorized or improper use of this system is prohibited and may result in disciplinary action and/or civil and criminal penalties.
Personal use of social media and networking sites on this system is limited as to not interfere with official work duties and is subject to monitoring.
By using this system, you understand and consent to the following:
The Government may monitor, record, and audit your system usage, including usage of personal devices and email systems for official duties or to conduct HHS business. Therefore, you have no reasonable expectation of privacy regarding any communication or data transiting or stored on this system. At any time, and for any lawful Government purpose, the government may monitor, intercept, and search and seize any communication or data transiting or stored on this system.
Any communication or data transiting or stored on this system may be disclosed or used for any lawful Government purpose.
No history of any cancer before trial and rare cancer during trial (Controls)
UCLA Serum and EDTA Plasma Available
Pre-Dx UCLA Serum and EDTA Plasma Available
Matching Factors:
Gender
Age level
Race
Study Year of Blood Draw
Date of Draw (+/- 365 days)
Match Ratio: 2:1
Match Technique: Individual matching without replacement only cases as controls.
Analytes:
Cancer Antigen 19-9
Thrombospondin-2
Number of Cases: 238
Number of Controls: 476
The following datasets contain the data available for 2016-0041. The description and documentation for each file is listed below. SAS7bdat and CSV versions of the actual data will be available to CDAS projects approved to use this data.
